Amwill Healthcare’s SME IPO, which opened on February 6, was fully subscribed by February 7, with retail, non-institutional, and QIB segments showing strong demand. The IPO has a price band of Rs 105-111 per share, with a GMP of Rs 5-6. Amwill, a derma-cosmetic firm, reported revenue of Rs 23.15 crore and profit of Rs 6.51 crore.
